McKesson (MCK) Tops Q3 EPS by 47c, Beats on Revenues; Offers FY18 EPS Guidance Above Consensus

Go back to McKesson (MCK) Tops Q3 EPS by 47c, Beats on Revenues; Offers FY18 EPS Guidance Above Consensus

McKesson (MCK) PT Lowered to $179 at Mizuho Securities Citing Weak Cash Flow

February 2, 2018 4:23 AM EST

Mizuho Securities lowered its price target on McKesson (NYSE: MCK) to $179.00 (from $186.00) while maintaining a Neutral rating.

... More

McKesson (MCK) PT Raised to $184 at Evercore ISI

February 1, 2018 12:15 PM EST

Evercore ISI raised its price target on McKesson (NYSE: MCK) to $184.00 (from $179.00) while maintaining a Outperform rating.

Analyst Ross Muken noted deflationary trends in generics seems to have settled to a more relatively stable environment. In addition, ClarusONE collaboration with WMT is progressing smoothly... More

Amazon, Berkshire, JPMorgan partner to cut U.S. healthcare costs

January 30, 2018 7:27 AM EST

By Caroline Humer and David Henry

NEW YORK (Reuters) - Amazon.com Inc (NASDAQ: AMZN), Berkshire Hathaway Inc and JPMorgan Chase & Co (NYSE: JPM) said on Tuesday they will form a company to cut health costs for hundreds of thousands of their employees, setting up a major challenge to an inefficient U.S. healthcare system.

The move by three of the best-known U.S. business leaders - Amazon's Jeff Bezos, Berkshire's Warren Buffett and JPMorgan's Jamie Dimon - would take on the world's most expensive... More